6505--Minneapolis VAMC Radiopharmaceutical Agent Pre-Solicitation Notice
ID: 36C26324R0053Type: Presolicitation
AwardedMar 25, 2024
$2.2M$2,227,933
AwardeeJUBILANT DRAXIMAGE RADIOPHARMACIES, INC. NORCROSS 30071
Award #:36C26324D0055
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNETWORK CONTRACT OFFICE 23 (36C263)Saint Paul, MN, 55101, USA

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/f8bb0f5d8342443b84c9e39eabfa5f4e/view
Timeline
    Description

    Presolicitation notice from the Department of Veterans Affairs for the procurement of radiopharmaceutical agents at the Minneapolis VAMC. Radiopharmaceutical agents are used in nuclear medicine to diagnose and treat various medical conditions. The procurement will take place at the Minneapolis VAMC located at 1 Veterans Drive, Minneapolis, MN 55417, USA. The primary contact for this procurement is Jeffrey Brown, Contracting Specialist, who can be reached at Jeffrey.Brown8@va.gov or 651-293-3009.

    Point(s) of Contact
    Jeffrey BrownContracting Specialist
    (651) 293-3009
    Jeffrey.Brown8@va.gov
    Files
    Title
    Posted
    36C26324R0053.docx
    36C26324R0053 0001.docx
    36C26324R0053 0002.docx
    36C26324R0053 0004.docx
    Pre-Solicitation (36C26324R0053).docx
    Similar Opportunities
    6505--Pylarify 2026 (VA-26-00025867) RFI
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified sources to provide F18 PSMA Pylarify, a radiopharmaceutical used for positron emission tomography (PET) imaging of prostate cancer, to the Baltimore VA Medical Center. The procurement aims to identify contractors capable of manufacturing, preparing, and transporting this specialized radiopharmaceutical in compliance with stringent regulatory standards, including USNRC, DOT, and FDA guidelines. Pylarify is critical for diagnosing prostate cancer by identifying PSMA-positive lesions, thus playing a vital role in patient care. Interested parties must submit their responses, including company information and qualifications, by December 17, 2025, at 10:00 AM EST, to Contract Specialist Michael Jones at michael.jones16@va.gov.
    Radiopharmaceuticals for Temple Texas VA Medical Center
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking a contractor to provide radiopharmaceuticals for the Olin E. Teague VA Medical Center in Temple, Texas, through a short-term contract lasting six months. This procurement is critical for the Nuclear Medicine Department, as the radiopharmaceuticals are essential for medical imaging and therapeutic treatments for various carcinomas, with a total estimated procurement cost of $445,000. The urgency of this requirement is underscored by the short shelf-life of the products, necessitating timely delivery to ensure continuous patient care for veterans. Interested vendors can contact Jeffrey Crysler at jeffrey.crysler@va.gov or by phone at 210-617-5300 for further details.
    6505--Notice of Intent to Award a Sole Source Procurement - Xofigo Radium-223 dichloride
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 17, intends to award a sole source, firm-fixed-price contract to Cardinal Health for the procurement of 660 units of XOFIGO® (Radium-223 dichloride). This procurement is based on a letter from Bayer Healthcare, which designates Cardinal Health as the sole distributor of XOFIGO® in the United States, highlighting the critical nature of this pharmaceutical in treating specific medical conditions. Interested parties may submit capability statements or proposals within seven days of the notice's publication, with the deadline set for December 19, 2025; otherwise, the contract will be awarded to Cardinal Health without further notice. For inquiries, contact Vance Farrell at vance.farrell@va.gov or call 210-694-6379.
    Radiopharmaceutical Laboratory Services (RLS) MAMC
    Dept Of Defense
    The Department of Defense, specifically the Madigan Army Medical Center, is conducting market research to identify qualified vendors capable of providing comprehensive Radiopharmaceutical Laboratory Services (RLS). The procurement aims to ensure that vendors can meet stringent requirements, including compliance with FDA standards, The Joint Commission accreditation, and the ability to deliver a range of specified radiopharmaceuticals on a 24/7 basis, including urgent requests. These services are critical for supporting medical operations that rely on radiopharmaceuticals for diagnostics and treatment. Interested parties must submit their capability statements to Cindy Means and Scott Barr by December 19, 2025, at 4:00 PM Pacific Time, detailing their qualifications and ability to meet the outlined requirements.
    6505--Biologics by McKesson Specialty Pharmacy (Lenalidomide) (VA-26-00016920)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers to provide Lenalidomide, a pharmaceutical product, for the Oscar G. Johnson VA Medical Center located in Iron Mountain, MI. This procurement will be conducted through a Brand Name or Equal Request for Quotation (RFQ) under firm-fixed price terms, following FAR Part 13 Simplified Acquisition Procedures. Lenalidomide is crucial for treating certain conditions, making this procurement significant for patient care within the VA system. Interested offerors must submit an itemized quote along with sufficient technical documentation via email to arneil.genus@va.gov by 3 p.m. Central on December 1, 2025, as telephone inquiries will not be accepted.
    J065--RSO Medical Physics Services KC
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for RSO Medical Physics Services at the Kansas City VA Medical Center and its Community-Based Outpatient Clinics. The contract encompasses a base year plus four one-year options, requiring services such as quarterly nuclear medicine audits, equipment inspections, and emergency RSO coverage, provided by a board-certified Medical or Health Physicist. This procurement is crucial for maintaining safety and compliance in medical physics operations, with an estimated contract value of $19 million. Proposals are due by December 23, 2025, at 10:00 AM CST, and interested parties should contact Contract Specialist Paul Dixon at paul.dixon@va.gov for further information.
    6525--SEP 2025 Equipment Only Consolidation
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the "SEP 2025 Equipment Only Consolidation" contract, specifically aimed at procuring medical imaging equipment and related services. This procurement encompasses a variety of medical devices, including but not limited to MRI systems, ultrasound units, and radiographic equipment, which are essential for enhancing diagnostic capabilities and improving healthcare delivery to veterans. The contract is unrestricted, with a due date for offers set for January 14, 2026, at 11:59 PM CST, and interested vendors can direct inquiries to Contracting Officer Teresa Rogofsky at teresa.rogofsky@va.gov. The solicitation includes detailed specifications and requirements, emphasizing compliance with security standards and the need for comprehensive training and support services.
    H258--Medical Physicist Services for William S. Middleton Memorial Veterans Hospital
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is conducting market research to identify qualified providers for Diagnostic Medical Physicist Services at the William S. Middleton Memorial Veterans Hospital in Madison, WI. The required services include inspections of various medical imaging equipment, acceptance testing, shielding design, safety training, annual quality assurance program reviews, and calculations of peak skin doses for patients. These services are critical for ensuring the safety and compliance of medical imaging operations within the facility. Interested parties must submit their capability statements by 10:00 AM Central Time on December 17, 2025, to joni.dorr@va.gov, as this is not a solicitation but a request for information to determine the procurement method.
    65--65VA RFP-797-655A-30-0001-R6 Solicitation Refresh
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is issuing a solicitation for the procurement of X-Ray Equipment and Supplies under the Federal Supply Schedule FSC Group 6525. This opportunity involves multiple award, fixed-price, indefinite delivery-indefinite quantity (IDIQ) contracts with Economic Price Adjustment (EPA) provisions, aimed at ensuring a continuous supply of essential imaging equipment and supplies for medical, dental, and veterinary use. The solicitation, designated as RFP-797-655A-30-0001-R6, is a refresh of a previous solicitation and remains open for new offers without a specified closing date, with contract performance expected to commence upon award and last for five years. Interested vendors can reach out to the FSS Help Desk at 708-786-7737 or via email at Fss.Help@va.gov for further inquiries.
    Y90 SIR Spheres
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to procure Y-90 SIR Spheres microspheres for use in Selective Internal Radiation Therapy (SIRT) at the North Texas Medical Center in Dallas, Texas. This contract involves the purchase of five unit doses of Sie-Spheres Y90 resin microspheres, estimated at $17,750 per dose, to ensure the availability of this critical treatment for patients with liver tumors. The unique characteristics of these microspheres, provided solely by Sirtex Medical, are essential for delivering targeted radiation therapy, as they are designed to lodge in tumor arterioles while minimizing exposure to healthy tissue. Interested parties can contact Contract Specialist Robert Clark at robert.clark15@va.gov or by phone at 512-228-1088 for further details regarding this procurement, which is justified under FAR 13.106-1 and is expected to exceed the micro-purchase threshold but remain under the simplified acquisition threshold of $250,000.